Siemens Healthcare Diagnostics, Inc. has recalled approximately 7,075 units of its Atellica CH Immunoglobulin M_2 (IgM_2) reagent kits due to a potential defect that causes a negative bias. This means that quality control tests and patient blood sample results may show lower levels of Immunoglobulin M than are actually present in the sample. This diagnostic reagent is used in clinical laboratories worldwide, including 927 units distributed across 41 U.S. states and Puerto Rico, for measuring immune system proteins.
The reagent may produce inaccurately low test results, which could lead to a misdiagnosis or incorrect monitoring of conditions related to the immune system. This negative bias affects both daily quality control checks and actual patient samples, potentially delaying necessary medical treatments or masking underlying health issues.
Contact healthcare provider or manufacturer
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.